Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Jason Zuckerbrod

Jason Zuckerbrod is a Partner at Centerview on the healthcare team. He has 15 years of experience advising companies on mergers and acquisitions, shareholder activism, and other complex strategic issues.

Select transactions Mr. Zuckerbrod has advised on include Express Scripts’s sale to Cigna for $67bn, Pfizer’s consumer healthcare joint venture with GSK, Tiffany & Co.’s sale to LVMH for $17bn, Pfizer’s acquisition of Medivation for $14bn, Biohaven’s sale to Pfizer for $12.5bn, Pfizer’s sale of its infant nutrition business to Nestle for $11.9bn, Acceleron’s sale to Merck for $11.5bn, Ventas’s acquisition of Nationwide Health Properties for $7.4bn, Pfizer’s acquisition of Arena for $6.7bn, Pfizer’s acquisition of Anacor for $5.2bn, Merck’s acquisition of Antelliq for €3.3bn, Chinook Therapeutics’s sale to Novartis for up to $3.5bn, Provention Bio’s sale to Sanofi for $2.9bn, DentaQuest’s sale to Sun Life for $2.5bn, Trillium’s sale to Pfizer for $2.3bn, Bellus Health’s sale to GSK for $2.0bn, CinCor Pharma’s sale to AstraZeneca for up to $1.8bn, Perrigo’s sale of its generics business to Altaris for $1.6bn, Chiesi Farmaceutici’s acquisition of Amryt Pharma for up to $1.5bn, Albireo’s sale to Ipsen for up to $1.2bn, VectivBio’s sale to Ironwood for $1.2bn, Gracell Biotech’s sale to AstraZeneca for up to $1.2bn, Inversago Pharma’s sale to Novo Nordisk for up to $1.075bn, Ventas’s spin-off of Care Capital Properties, Anthem’s acquisition of America’s First Choice, Perrigo’s acquisition of Ranir for $750mm, ReViral’s sale to Pfizer for up to $525mm, MiroBio’s sale to Gilead for $405mm, Checkmate’s sale to Regeneron for $250mm, ProPharma Group’s sale to Odyssey, Thirty Madison’s acquisition of Nurx, and Express Scripts’s sale of UBC to Avista Capital.

Prior to joining Centerview, Mr. Zuckerbrod was an analyst at Berenson & Company. He received a B.A., magna cum laude, from Columbia University and lives in Rye, NY with his wife, son, and daughter.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
CapVest Partners LLP
Announced: Q2 2024
Status: Closed

Financial advisor to CapVest on its partial equity recapitalization of Datasite LLC
View All
New York

Centerview Partners LLC

31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax

Centerview Partners UK LLP

1 Sherwood Street

6th Floor

London W1F 7BL

02074099700 | Tel
02074099704 | Fax

Centerview Partners France SCS

51 Avenue Hoche

Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC

1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC

555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax

Copyright © 2008 - 2024 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC